The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| IDXX | +78.51% | +65.75% | +10.62% | +79,544% |
| S&P | +14.18% | +88.25% | +13.47% | +1,713% |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Investors were barking for some shares thanks to a better-than-expected earnings report.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.11B | 13.3% |
| Gross Profit | $685.32M | 15.1% |
| Gross Margin | 62.01% | 1.0% |
| Market Cap | $51.11B | 22.9% |
| Market Cap / Employee | $4.65M | 0.0% |
| Employees | 11K | 0.0% |
| Net Income | $274.61M | 17.9% |
| EBITDA | $393.44M | 16.6% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $208.17M | -32.6% |
| Accounts Receivable | $638.83M | 11.6% |
| Inventory | 391.6 | 0.5% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $481.32M | -23.4% |
| Short Term Debt | $631.64M | 70.7% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 30.50% | 3.6% |
| Return On Invested Capital | 42.63% | -0.8% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $371.23M | 93.4% |
| Operating Free Cash Flow | $402.34M | 82.8% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 38.76 | 38.80 | 44.64 | 50.65 | 3.90% |
| Price to Book | 20.96 | 21.48 | 29.91 | 35.10 | 37.03% |
| Price to Sales | 8.76 | 8.75 | 10.76 | 12.37 | 13.32% |
| Price to Tangible Book Value | 30.86 | 31.77 | 46.41 | 54.44 | 44.37% |
| Price to Free Cash Flow TTM | 42.23 | 40.58 | 55.38 | 53.49 | 1.04% |
| Enterprise Value to EBITDA | 119.05 | 99.62 | 109.20 | 133.30 | 5.49% |
| Free Cash Flow Yield | 2.4% | 2.5% | 1.8% | 1.9% | -1.03% |
| Return on Equity | 57.7% | 59.3% | 64.9% | 64.6% | 8.77% |
| Total Debt | $986.95M | $1.06B | $1.24B | $1.11B | 11.49% |
IDXX earnings call for the period ending June 30, 2022.
IDXX earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
